Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study

International Journal of Antimicrobial Agents

Volumn 40, Issue 6, 2012, Pages 516-520

  Shigemura, Katsumi ^a   Tanaka, Kazushi ^a   Yamamichi, Fukashi ^a   Shirakawa, Toshiro ^a,b   Miyake, Hideaki ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Efflux pump; Escherichia coli; Fluoroquinolone resistance; Mutation; Quinolone resistance determining region (QRDR); Statistical analysis study; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE; SITAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENE EXPRESSION; GENE MUTATION; GYRA GENE; MARA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; URINARY TRACT INFECTION; YHIU GENE;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTANT PROTEINS; MUTATION, MISSENSE; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; URINARY TRACT INFECTIONS;

EID: 84869509761     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.07.019     Document Type: Article

References (24)

1. M.S. Bader, J. Hawboldt, and A. Brooks Management of complicated urinary tract infections in the era of antimicrobial resistance Postgrad Med 122 2010 7 15
2. P.D. Brown Management of urinary tract infections associated with nephrolithiasis Curr Infect Dis Rep 12 2010 450 454
3. A. Ronald The etiology of urinary tract infection: traditional and emerging pathogens Am J Med 113 Suppl. 1A 2002 14S 19S (Pubitemid 34756641)
4. T. Yasufuku, K. Shigemura, T. Shirakawa, Y. Nakano, K. Tanaka, and S. Arakawa Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections Scand J Infect Dis 43 2011 83 88
5. X.Z. Li, and H. Nikaido Efflux-mediated drug resistance in bacteria Drugs 64 2004 159 204 (Pubitemid 38186964)
6. M. Viveiros, M. Martins, I. Couto, L. Rodrigues, G. Spengler, and A. Martins New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps Curr Drug Targets 9 2008 760 778
7. T. Yasufuku, K. Shigemura, T. Shirakawa, M. Matsumoto, Y. Nakano, and K. Tanaka Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients J Clin Microbiol 49 2011 189 194
8. Clinical and Laboratory Standards Institute. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
10. T. Muratani, and T. Matsumoto Bacterial resistance to antimicrobials in urinary isolates Int J Antimicrob Agents 24 Suppl. 1 2004 S28 S31
11. J. Turnidge, J. Bell, D.J. Biedenbach, and R.N. Jones Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999 Int J Antimicrob Agents 20 2002 10 17 (Pubitemid 34778462)
12. Y.S. Yang, C.H. Ku, J.C. Lin, S.T. Shang, C.H. Chiu, and K.M. Yeh Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections J Microbiol Immunol Infect 43 2010 194 199
13. G.G. Zhanel, N.M. Laing, K.A. Nichol, L.P. Palatnick, A. Noreddin, and T. Hisanaga Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS) J Antimicrob Chemother 52 2003 382 388 (Pubitemid 37120716)
14. D.N. Zhao, Y.H. Xiao, S.L. Zhang, and X.X. Wang Bacterial composition and resistance from urinary tract infections in females Zhonghua Fu Chan Ke Za Zhi 44 2009 32 37 [in Chinese]
15. J.M. Pagès, A.F. Sandrine, A. Mahamoud, J.M. Bolla, A. Davin-Regli, and J. Chevalier Efflux pumps of Gram-negative bacteria, a new target for new molecules Curr Top Med Chem 10 2010 1848 1857
16. J.H. Shin, H.J. Jung, J.Y. Lee, H.R. Kim, J.N. Lee, and C.L. Chang High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea Microb Drug Resist 14 2008 221 226
17. X. Yu, M. Susa, J. Weile, C. Knabbe, R.D. Schmid, and T.T. Bachmann Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray Int J Med Microbiol 297 2007 417 429 (Pubitemid 47375178)
18. Y. Morita, J. Tomida, and Y. Kawamura Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7 Microbiology 158 2012 1071 1083
19. R. Singh, M.C. Swick, K.R. Ledesma, Z. Yang, M. Hu, and L. Zechiedrich Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli Antimicrob Agents Chemother 56 2012 1680 1685
20. J.K. Lee, Y.S. Lee, Y.K. Park, and B.S. Kim Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea Microbiol Immunol 49 2005 647 653 (Pubitemid 41289351)
21. S. Bansal, and V. Tandon Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates Int J Antimicrob Agents 37 2011 253 255
22. D.C. Moon, S.Y. Seol, M. Gurung, J.S. Jin, C.H. Choi, and J. Kim Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates Int J Antimicrob Agents 35 2010 76 79
23. N. Christiansen, L. Nielsen, L. Jakobsen, M. Stegger, L.H. Hansen, and N. Frimodt-Moller Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country Microb Drug Resist 17 2011 395 406
24. L. Poirel, R.A. Bonnin, and P. Nordmann Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing Antimicrob Agents Chemother 55 2011 4224 4229